Effective interventions for lifestyle change after myocardial infarction or coronary artery revascularization by Davis, Leslie L & NC DOCKS at The University of North Carolina at Greensboro
Effective interventions for lifestyle change after myocardial infarction or coronary artery 
revascularization 
 
By: Stephanie L. Cobb, Debra J. Brown, and Leslie L. Davis 
 
Cobb, S. L, Brown, D. J., Davis, L.L.  (2006). Effective interventions for lifestyle changes after 
myocardial infarction and coronary artery revascularization. Journal of American Academy Of 
Nurse Practitioners, 18(1), 31-39. 
 
***© Wiley. Reprinted with permission. No further reproduction is authorized without 
written permission from Wiley. This version of the document is not the version of record. 
Figures and/or pictures may be missing from this format of the document. *** 
 
This is the peer reviewed version of the following article: Cobb, S. L, Brown, D. J., Davis, 
L.L.  (2006). Effective interventions for lifestyle changes after myocardial infarction and 
coronary artery revascularization. Journal of American Academy Of Nurse Practitioners, 
18(1), 31-39., which has been published in final form at http://dx.doi.org/10.1111/j.1745-
7599.2006.00096.x. This article may be used for non-commercial purposes in accordance 




Purpose: This science clinical paper reviews medical literature and examines interventions that 
are currently used to assist patients in achieving lifestyle change after myocardial infarction or 
coronary artery revascularization. Interventions that focused on both provider- and patient-
implemented strategies were included. The effectiveness of these interventions to significantly 
reduce coronary heart disease risk factors was explored. 
 
Data sources: Original longitudinal research studies or reviews indexed in PubMed between 
1999 and 2004 were included. Eight studies were identified that met the inclusion criteria and 
presented successful interventions to increase participants’ adherence to recommended lifestyle 
changes. 
 
Conclusions: Current strategies for achieving recommended risk factor reductions include 
frequent follow-up, intensive diet changes, individualized and group exercise, coaching, group 
meetings, education on lifestyle modification and behavior change, and formal cardiac 
rehabilitation programs. 
 
Implications for practice: Nurse Practitioners can help close the gap between evidence-based 
recommendations and clinical practice by implementing education programs in their practices 
and in the community. Recommendations include frequent follow-up visits, negotiating 
personalized treatment plans, and a general emphasis on therapeutic lifestyle change as an 
essential component of the treatment plan. 
 
Keywords: Coronary artery disease | coronary heart disease | therapeutic lifestyle change | risk 






Coronary heart disease (CHD) is the leading cause of death for both men and women in the 
United States, killing more than 500,000 Americans in 2001. Although the CHD death rate 
decreased 46% from 1981 to 2001, acute myocardial infarction (MI) remains the leading cause 
of CHD mortality, representing 20% of all CHD deaths in 2001. Thirteen million Americans are 
living with CHD (National Heart, Lung, & Blood Institute, 2003), with an estimated 700,000 
experiencing a new MI and 500,000 with recurrent MIs in 2004. Survivors of the acute stage of 
MI have a risk of illness and death as much as 15 times higher than the general population, and 
approximately two thirds fail to make a complete recovery (American Heart Association, 2003). 
Consequently, patients with preexisting CHD are the first priority in preventive cardiology. 
 
A multitude of known CHD risk factors exist, including male sex, increasing age, family history 
of CHD, diabetes mellitus, cigarette smoking, hypertension (HTN), dyslipidemia, overweight 
and obesity, lack of physical activity, alcohol use, and dietary factors such as high salt and fat 
intake (Khot et al., 2003; Pearson et al., 2002; Stamler et al., 1999; United States Department of 
Health and Human Services [U.S. DHHS], 2000). Many of these risk factors are not limited to an 
association with CHD; they also contribute to increased risk for other leading causes of death 
such as stroke, cancer, and lung diseases. In addition, several risk factors are correlated. For 
example, decreased physical activity not only independently increases CHD risk but also 
increases the risk of obesity, HTN, dyslipidemia, and diabetes, each of which further intensifies 
CHD risk (Pearson et al., 2002; U.S. DHHS). 
 
Several studies have demonstrated that the reduction of risk factors is still effective in decreasing 
both recurrent coronary events and cardiovascular disease mortality in patients who have already 
experienced MI or coronary artery revascularization (Ornish et al., 1990, 1998; Sdringola et al., 
2003; Wallner et al., 1999). Therefore, CHD risk factor identification and treatment, including 
therapeutic lifestyle change, is crucial to managing the care of patients with preexisting CHD. 
 
Despite healthcare providers’ efforts to manage risk factors and the many campaigns and 
strategies employed to inform the public, the vast majority of patients with CHD (85%–100%) 
have at least one significant modifiable risk factor (defined as cigarette smoking, HTN, diabetes, 
or hyperlipidemia) (Greenland et al., 2003; Khot et al., 2003; Stamler et al., 1999). There is a 
“treatment gap” between what is recommended based on scientific evidence and the reality of 
clinical practice (Pearson, Laurora, Chu, & Kafonek, 2000; The EUROASPIRE Study Group, 
1997). This paper will present strategies for closing the treatment gap through effective 




This paper reviews the medical literature and examines interventions that are currently used to 
assist patients in achieving lifestyle change after MI or coronary artery revascularization. 
Because achieving lifestyle change requires the expertise of the provider and cooperation from 
the patient, interventions that focused on both provider- and patient-implemented strategies were 
included. The effectiveness of these interventions to significantly reduce CHD risk factors was 
explored. Lastly, implications for nurse practitioners (NPs) and recommendations for best 




A PubMed search was conducted using the key words myocardial ischemia, myocardial 
revascularization, health behavior, and patient education with the subheadings prevention and 
control, diet therapy, and rehabilitation. Only original longitudinal research studies or reviews 
with the following characteristics were considered: studies involving adult human participants of 
both sexes over age 18 years diagnosed with MI, coronary artery revascularization (by coronary 
artery bypass graft [CABG] or percutaneous coronary intervention [PCI]), or both who 
participated in an intervention designed to increase participants’ adherence to recommended 
lifestyle changes and were published in English between 1999 and 2004. Studies that evaluated 
the effectiveness of medication therapy on modifiable risk factors were excluded. Eight studies 
with successful interventions were included in the review. Interventions were considered 





The Lifestyle Heart Trial was the first randomized controlled clinical trial evaluating the effects 
of therapeutic lifestyle change on the regression of coronary atherosclerosis. Its demonstration by 
angiography that significant reductions in coronary stenosis were possible began the researcher's 
quest to determine which lifestyle behaviors should be given priority for change and the degree 
of intensity required to delay progression or induce regression of CHD (Ornish et al., 1990). 
 
Wallner et al. (1999) examined the need for additional revascularization procedures in patients 
after PCI who implemented Ornish-based therapeutic lifestyle change. Sixty patients with 
successful PCI were randomly assigned to either a therapeutic lifestyle change intervention 
group or a control group and were blinded to their assignment. Successful PCI was defined as 
postprocedure stenosis less than 50% without restenosis in 24 h. Both groups received identical 
diet and lifestyle advice from a nutritionist at baseline. The control group received usual care 
from a general practitioner and was seen every 3 months, while the intervention group had 1-h 
Ornish program sessions with the nutritionist every week for 1 month, every 2 weeks for 2 
months, then monthly until 12 months. Blood samples were collected from both groups at 
baseline and 12 months, and 4-day food records were obtained from intervention group 
participants at each nutritionist visit. All patients were treated by the study cardiologist if clinical 
signs of ischemia developed. The need for revascularization by either CABG or PCI was 
determined by a study cardiologist who was blinded to group assignment. The mean observation 
time was 26 months. This extended observation time, combined with random assignment, 
blinding of the participants and study cardiologist, and recruitment of enough participants to 
detect a 35% risk reduction with a power of 90%, is a major strength of the study. 
 
Despite having more previous MIs, higher systolic blood pressure (BP), and higher physical 
activity compared to the control group at baseline, the intervention group significantly improved 
physical activity; total, saturated, and monounsaturated fat intake; carbohydrate and fiber intake; 
and dietary cholesterol. Body mass index (BMI), lean body mass, body fat, systolic BP, diastolic 
BP, total cholesterol (TC), and low-density lipoprotein (LDL) cholesterol all improved in the 
intervention group at 12 months compared to baseline, with p < .01 (see 1Table 1). During the 
study period, 17 revascularization procedures were required, 3 in the intervention group and 14 
in the control group, with two participants in the control group experiencing both an additional 
PCI and a CABG. Therapeutic lifestyle changes made by the intervention group participants 
resulted in a 74% decrease in the need for coronary artery revascularization, with p < .01 
(Wallner et al., 1999). 
 
Table 1. Selected Results from Noncomparative Studies 
Note. SBP, systolic blood pressure; DBP, diastolic blood pressure; RN, registered nurse; LPN, 
licensed practical nurse; TC, total cholesterol; LDL, low-density lipoprotein; BMI, body mass 
index; HDL, high-density lipoprotein. 
 
Aldana et al. (2003) also studied the effects of the Ornish program but compared it with 
traditional cardiac rehabilitation and a control group in participants with MI and either CABG or 
PCI. After watching a video that described both intervention programs, participants self-selected 
their group. Data were collected at baseline, 3 months, and 6 months, including fasting lipid 
levels, glucose, diet, weight, BMI, waist to hip ratio, BP, angina severity, 3-day diet diaries, and 
exercise questionnaires. There were no significant differences between the groups at baseline 
except that the control group had lower high-density lipoprotein (HDL) cholesterol. Limitations 
of the study included the use of a convenience sample, the self-selection of participants into 
groups, and the additional motivation provided by giving participants $50 at each study visit. The 
authors acknowledged the possible bias income levels may have had in the participants’ selection 
of a group and randomly matched those in the Ornish group with those in the rehabilitation and 
control groups to create sets of triplets to be used in all analyses. 
 
Both intervention groups showed improvements in risk factors after 6 months. Although the 
cardiac rehabilitation participants had significant reduction in waist to hip ratios and increased 
HDL cholesterol, the Ornish program participants significantly improved BMI, weight, systolic 
BP, TC, LDL, fasting glucose, and dietary fat intake compared to the cardiac rehabilitation and 
control groups. Cardiac rehabilitation participants’ weight, BMI, and BP significantly worsened, 
while the control group's risk factors either worsened or did not change. Medication use was not 
measured or factored into the results. Although cardiac rehabilitation participants made greater 
improvements than the control group, the comprehensive therapeutic lifestyle change made by 
participants in the Ornish program was the most effective in reducing risk factors (Aldana et al., 
2003). 
 
Gordon et al. (2002) also found risk factor reductions in patients with MI, CABG, PCI, or angina 
who participated in traditional cardiac rehabilitation when comparing cardiac rehabilitation with 
physician-supervised nurse case management and a community-based exercise program run by 
exercise physiologists. All three interventions successfully decreased risk factors, with 
significant improvements in systolic and diastolic BP, TC, LDL cholesterol, and weight. There 
were no statistical differences in risk factor improvement between the three groups. Significant 
improvement in triglycerides was seen in patients in the cardiac rehabilitation and community-
based groups who had abnormal baseline values (see 2Table 2). There was no control group for 
comparison. 
 
Table 2.  Selected Results from Comparative Studies 
Note. SBP, systolic blood pressure; DBP, diastolic blood pressure; AHA, American Heart 
Association; RN, registered nurse; MD, doctor of medicine; TC, total cholesterol; LDL, low-
density lipoprotein; HDL,high-density lipoprotein; BMI, body mass index. 
 
Lisspers et al. (1999) developed a lifestyle change cardiac rehabilitation program for patients 
under 60 years who had MI, CABG, or PCI. This comprehensive 12-month program began with 
a 4-week inpatient stay and involved (a) health education on stress, diet, exercise, and smoking 
cessation, (b) behavior change, (c) skills training, (d) practicing new habits, (e) group and 
individual counseling, and (f) relapse prevention. Each participant had a designated registered 
nurse as a personal coach. Data were collected at baseline, 4 weeks, and 12 months on a broad 
range of lifestyle, biologic, and psychological risk factors and outcomes. Lipids improved at 4 
weeks and 12 months. Twelve-month means for TC had decreased from 6.4 to 5.8 mmol/L (248–
224 mg/dL), triglycerides decreased from 2.3 to 2.0 mmol/L (89–77 mg/dL), and the LDL/HDL 
ratio decreased from 4.3 to 3.8 mmol/L (166–147 mg/dL), all p < .0001. BMI was decreased by 4 
weeks and maintained until the 12-month follow-up, when the mean BMI was 26. Sixty percent 
of smokers quit during the program and had not resumed by 12 months. Although the results 
demonstrated considerable improvement, there was no control group for comparison. 
 
Vale, Jelinek, Best, and Santamaria (2002) also used coaching in an effort to close the treatment 
gap and achieve recommended target cholesterol levels. Patients who were hospitalized for PCI 
or CABG at a single teaching hospital in Australia were assigned to two groups by random 
numbers and stratified by type of procedure. The control group received usual care, while the 
intervention group received usual care as well as the coaching intervention. The coaching was 
targeted at the participants, who were expected to know their risk factors and risk factor goals 
and to ask for medical therapy from their primary care provider as appropriate. Participants in the 
intervention group were contacted by the coach by phone 2 weeks after randomization and then 
three additional times at 6-week intervals, with a reminder call at 24 weeks to schedule the 6-
month blood sample. Control group participants were contacted 2 weeks after randomization for 
a “how are you?” phone call and then at 24 weeks to schedule the 6-month blood sample. Both 
groups were encouraged to participate in a separate cardiac rehabilitation program. 
 
Each of the coaching interventions followed a quality improvement cycle that involved (a) 
asking questions to evaluate participants’ knowledge, attitudes, and beliefs about their risk 
factors, (b) educating as needed and explaining the treatments recommended to achieve risk 
factor goals, (c) training in assertiveness to assist in receiving information from the treating 
physician as well as requesting appropriate medication therapy, (d) setting goals for the next 
coaching session and negotiating a plan of action, and (e) reassessing at the next coaching 
session. All coaching sessions were conducted by the lead author, a dietician with educational 
and cardiovascular experience (Vale et al., 2002). 
 
The two groups were comparative at baseline, but at 6 months the intervention group's TC levels 
were significantly less than the control group’s, and 31% of coached participants compared to 
10% of control participants achieved the target TC of less than 4.5 mmol/L (174 mg/dL), the 
recommended Australian goal. Baseline TC, coaching, and medication therapy were the 
independent predictors of endpoint TC; however, there were no significant differences between 
groups in the prescription or dosage of lipid-lowering drugs at 6 months. Neither the type of 
revascularization procedure nor participation in cardiac rehabilitation affected TC (Vale et al., 
2002). 
 
Several limitations of Vale et al.'s 2002 study (participant recruitment from a single medical 
center, the intervention's implementation by a single coach, and a single time frame for follow-
up on selected risk factors) were resolved in the expansion of the project by Vale et al. in 2003. 
Six additional coaches were trained, and each coach conducted interventions with participants 
from six university teaching hospitals, one coach per hospital. The focus in this study was the 
change in TC over a 6-month period as well as the effect of coaching on multiple risk factors. As 
in the pilot study (Vale et al., 2002), participants in the intervention group were expected to 
know their personal risk factors and risk factor goals and how to achieve them, and to see their 
healthcare provider and request appropriate medication therapy. Intervention group participants 
were also expected to follow recommended therapeutic lifestyle changes, with anticipated better 
adherence to diet recommendations and the treatment plan prescribed by their provider (Vale et 
al., 2003). 
 
Each hospital recruited 140 patients who had CABG, PCI, MI, or angiography with planned 
coronary artery revascularization; after obtaining informed consent, 792 were randomized to 
either the coaching or control group. Baseline data were collected by review of medical records, 
interviews, and diet and psychological questionnaires while participants were inpatients. 
Participants were assigned to groups by random numbers and stratified by procedure. The 
intervention group was mailed a copy of their individual risk factor levels (e.g., BMI 
classification as low, moderate, or high risk) and a chart of risk factor goals. A copy of the risk 
factor target chart was mailed to the primary care provider for both the intervention and control 
groups. Intervention group participants received coaching sessions by phone (as described 
above) at 2 weeks, followed by three sessions at 6-week intervals and a final call at 24 weeks to 
arrange for the 6-month risk factor assessment. Targeted risk factors were expanded to include 
not only TC but also smoking cessation, BP, fasting blood glucose, BMI, saturated fat intake, 
and physical activity in accordance with Australian national guidelines. The usual care group 
was only contacted at 24 weeks to arrange for the 6-month risk factor assessment (Vale et al., 
2003). 
 
There were no significant differences between the two groups at baseline; however, at 6 months 
the intervention group had significantly decreased their TC an average of 0.54 mmol/L compared 
to 0.18 mmol/L in the control group (21 vs 7 mg/dL). Compared with the control group, coached 
participants had significantly greater improvement in weight, BMI, total fat, saturated fat, and 
cholesterol intake, and increased walking frequency (but not longer duration). There was no 
statistically significant difference in fasting blood glucose, smoking cessation, and cardiac 
rehabilitation attendance between the groups (Vale et al., 2003). In contrast to the pilot study 
(Vale et al., 2002), at 6 months more participants in the intervention group were on statins for 
cholesterol reduction; however, the effect of coaching on TC was significant, with p < .0001 
(Vale et al., 2003). 
 
Gleason et al. (2002) conducted a more focused study examining LDL and weight changes. The 
authors investigated whether home-delivered prepared meals and telephone diet education to 
patients diagnosed with CHD (defined as MI, coronary artery revascularization, angiography, or 
angina with a positive stress test) would improve dietary compliance and quality of life while 
reducing LDL cholesterol and weight. Patients with diabetes mellitus, uncontrolled angina, or 
HTN were excluded from this 8-week study. Participants were called weekly for encouragement, 
feedback on progress, and an opportunity to ask questions. Participants were also given written 
information on physical activity, walking, beverages, recipes, and tips for shopping, eating out, 
and snacking. For the first 4 weeks, lunch and dinner were provided as prepared meals. For the 
second half of the study, suggestions were made for appropriate lunch substitutions and dinner 
was delivered as prepared meals. Menu plans met the National Cholesterol Education Program 
(NCEP) Step II Diet guidelines. At 8 weeks, total and LDL cholesterol, weight, and BMI were 
significantly reduced, with no significant changes in triglycerides or HDL cholesterol. The 8-
week follow-up period and lack of a control group limit the strength of the findings. The 
intervention itself (i.e., providing prepared meals) may have limited utility in clinical practice. 
 
Masley, Phillips, and Copeland (2001) also studied dietary changes. The focus was on 
encouraging patients with coronary artery disease (based on unspecified hospital coding data) to 
increase their consumption of fruits, vegetables, and legumes while changing fat intake to more 
monounsaturated and n-3 fatty acid sources. Participants were divided into two groups with 
equivalent LDL cholesterol levels and then randomly assigned to either the intervention or 
control group. The intervention group participated in free group classes once a week for the first 
month and then monthly for a year. Classes were taught by a licensed practical nurse and 
involved diet education, cooking demonstrations, and encouragement to be physically active. 
They also received a textbook with shopping lists, menu plans, and food-monitoring sheets. 
Control group participants received handouts on the NCEP Step II or III Diet and American 
Heart Association menu plans but no group visits. Fasting lipids and hemoglobin A1c levels 
were collected at baseline and 12 months, while food questionnaires were collected at baseline, 3 
months, and 12 months. 
 
The intervention group had a significant increase in their self-reported consumption of fruits and 
vegetables compared to baseline and a significant 45% increase in the use of monounsaturated 
cooking oils compared with a 1% increase in the control group. The intervention group also 
significantly reduced LDL levels by 0.34 mmol/L (13 mg/dL). However, the reduction was not 
significantly greater than that seen in the control group. Changes in TC/HDL ratio, HDL 
cholesterol, and triglyceride levels were not significantly different. The self-reported dietary 
results introduce potential bias, and results of this study should be interpreted cautiously because 
the study had inadequate power because of a higher than expected dropout rate. The researchers 
calculated that of the 120 participants recruited, 23 could withdraw without decreasing the power 






All the interventions studied involved contact with a healthcare professional more frequently 
than is commonly seen in usual care, through either phone calls, office visits, or group visits. 
Although several studies had a control group, none of the control groups received contact with a 
healthcare professional as often as the intervention groups (Aldana et al., 2003; Masley et al., 
2001; Ornish et al., 1990; Vale et al., 2002, 2003; Wallner et al., 1999), making it difficult to 
determine to what degree the frequency of contact influenced the success of the interventions 
implemented. Possibly, the accountability inherent in meeting or talking with a healthcare 
professional had an additive effect in helping the participants continue the recommended 
therapeutic lifestyle changes. 
 
While lipid-lowering medications have become a mainstay of CHD management in the past 
several years, these studies demonstrate that therapeutic lifestyle change is still beneficial for risk 
factor management. Although Vale et al. (2003) found medication therapy to have the single 
greatest effect on TC levels, the coaching intervention that encompassed both appropriate 
medication therapy and therapeutic lifestyle change had an independent, statistically significant 
(p < .001) effect on lowering cholesterol as well as other risk factors. 
 
All studies reviewed had some level of education about a heart-healthy diet, but four studies 
specifically involved nutritionists in direct contact with participants (Gleason et al., 2002; Vale et 
al., 2002, 2003; Wallner et al., 1999). Several others involved registered or licensed practical 
nurses in patient education and management (Aldana et al., 2003; Gordon et al., 2002; Lisspers 
et al., 1999; Masley et al., 2001; Vale et al., 2003); one study used exercise physiologists to 
deliver diet and lifestyle information (Gordon et al.). Although risk factor improvement was seen 
in all studies regardless of the healthcare professional providing the patient education, these 
assistants were highly trained to provide the specific intervention implemented. Further research 
on the effect of education by healthcare professionals of different specialties is warranted. 
 
Various methods were used to encourage increased physical activity. Some participants were 
given verbal advice or written information (Gleason et al., 2002; Lisspers et al., 1999; Masley et 
al., 2001; Wallner et al., 1999), but other studies encouraged participation in a cardiac 
rehabilitation program (Vale et al., 2002, 2003), prescribed individual exercise plans (Gordon et 
al., 2002; Ornish et al., 1990), or involved group exercise (Aldana et al., 2003). 
 
The three studies that examined smoking behavior reported mixed results. Lisspers et al. (1999) 
reported that through extensive education and lifestyle change coaching with both individual and 
group meetings, 60% of smokers quit smoking during the study. In Gordon et al.'s (2002) 
comparison of cardiac rehabilitation, nurse case management, and a community-based program, 
16 participants were smoking at baseline and 4 quit during the course of the program. There were 
no differences in smoking cessation rates between the three groups; however, it was a small 
number of participants who were smoking. Similarly, Vale et al. (2003) found the coaching 
intervention had no significant effect on smoking cessation (see Tables 1 and 2). 
 
Recent research suggests other interventions may be equally effective when compared to cardiac 
rehabilitation. Gordon et al. (2002) found that physician-supervised nurse case management, a 
community-based program run by exercise physiologists, and cardiac rehabilitation all 
significantly improved participants’ systolic and diastolic BP, total and LDL cholesterol, and 
weight. In contrast, in Aldana et al.'s (2003) study comparing the Ornish program with cardiac 
rehabilitation and a control group, participants in rehabilitation significantly improved their waist 
to hip ratio and HDL levels but also significantly worsened weight, BMI, and BP (see Table 2). 
Aldana et al. concluded that except for increased HDL levels, the rehabilitation group's risk level 
was similar to the control group’s, who either had no change or experienced worsening of their 
risk factor status during the study. In both studies, Vale et al. (2003, 2002) found that for those 
participants who chose to participate in cardiac rehabilitation, the rehabilitation had no effect on 




The connection between minimizing CHD risk factors and reducing morbidity and mortality is 
well established. CHD's rank as the leading cause of death and the high prevalence of modifiable 
risk factors makes it imperative for healthcare providers to eliminate the treatment gap between 
evidence-based recommendations and actual clinical practice. Current strategies for achieving 
recommended target risk factor levels include frequent follow-up, intensive diet changes, 
individualized and group exercise, coaching, group meetings, education on lifestyle modification 
and behavior change, and formal cardiac rehabilitation programs. 
 
Recommendations for practice 
 
Although many of the interventions performed in the reviewed studies may be impractical to 
implement as described, they can be modified and applied in daily practice. If healthcare 
providers can assist their patients in achieving therapeutic lifestyle change, they can close the 
treatment gap by bringing current clinical practice in line with evidence-based recommendations, 
resulting in healthier lives for patients and their families. 
 
One strategy that all studies had in common was increased contact with a healthcare provider. 
When implementing therapeutic lifestyle change aimed at any risk factor, healthcare providers 
should schedule frequent and regular follow-up (e.g., monthly) to monitor progress and provide 
time for questions and encouragement, either in person or by telephone. Providers can offer 
support groups for patients in their practice who are implementing therapeutic lifestyle change or 
encourage patients to attend groups outside the medical arena, such as local senior centers, 
YMCAs, or Weight Watcher's meetings. 
 
Special attention should be given to implementing therapeutic lifestyle change in addition to 
medication therapy. It should be emphasized to patients that the beginning of medication is not 
the end of therapeutic lifestyle change; they are “equal, independent and additive in their effects” 
(Vale et al., 2002, p. 249). Strategies need to be personalized to individual patients, considering 
their other health problems and risks as well as cultural and financial issues that influence 
behavior change. Involving the patient in goal setting and writing down the plan of action (such 
as an individualized exercise plan) gives the patient concrete steps to follow and illustrates the 
importance the provider places on therapeutic lifestyle change. Although evidence suggests that 
other methods of achieving therapeutic lifestyle change can produce benefits that are similar to 
those seen with cardiac rehabilitation, healthcare providers should continue to refer patients to 
cardiac rehabilitation programs while also implementing other strategies for lifestyle change. 
Implications for nurse practitioners 
 
As healthcare providers specifically trained in health promotion, patient education, and 
communication skills, NPs are ideally suited to implement these strategies in their patient 
populations. NPs in direct patient care can use their knowledge of the patient and family to 
personalize care and negotiate goals and plans of action agreeable to the patient, as well as to 
start and manage appropriate medication therapy. NPs can also help close the treatment gap 
between evidence-based recommendations and clinical practice by implementing education 
programs in medical practices and the community, promoting public and workplace policies that 
support a healthy lifestyle and performing new research in the effort to control and cure CHD. 
Using these strategies, NPs can promote positive change toward minimizing the effect of CHD, 
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